|
|
| Year : 1991 | Volume
: 36
| Issue : 2 | Page : 21-27 |
|
|
Double-blind comparison of mometasone furoate 0.1 percent and betamethasone valerate 0.12 percent creams in dermatoses
SK Panja, A Marwah, SD. Sharma
Department of Dermatology & STD National Medical College & Hospital, Calcutta
Correspondence Address:
SK Panja
Department of Dermatology & STD National Medical College & Hospital, Calcutta
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
ABSTRACT: The efficacy and safety of mometasone furoate 0.1 percent cream, a formulation of a new non-fluorinated topical steroid, were evaluated in comparison with those of betamethasone valerate 0.12 percent cream. Both creams were applied twice-daily for 21 days in this randomised, double-blind, parallel- group clinical study. One hundred thirty-five patients (68 plus 67) of moderate to severe dermatoses completed the study. Three cardinal signs (erythema, induration, pruritus) together with physician's global evaluation during each weekly follow-up were the criteria of efficacy. Both drugs were efficacious in treating dermatoses. However, mometasone furoate was significantly more effective as compared to betamethasone valerate. Only one patient in each treatment group showed an adverse drug effect. |
|
|
|
| [PDF Not available]* |
|
 |
|
